DaclaHep (Daclatasvir) is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection. Compared to other treatment options, this combination not only...
With our vast market experience along with highly efficient team of supervisors, we have been able to create a niche in the international market. Situated in Mumbai, Maharashtra, we are a name to reckon with among the foremost exporters and...